Following a difficult first quarter in which it reported anemic organic revenue growth of 3 percent, Waters last week reported that its organic second-quarter revenues rose 8 percent year over year. The rebound brought relief to investors and others in the life sciences capital equipment market who have been closely monitoring pharma spending trends. This week, Gene Cassis, Waters' vice president of investor relations, spoke with BioCommerce Week about reasons for the firm's improved quarterly results and the current capital equipment market.

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.

A fire at a Manchester hospital may have destroyed lab equipment and data, the Guardian reports.

Researchers generate a genetic database from skeletal remains from the 1845 Franklin Expedition to the Arctic, Live Science reports.

Researchers in China have begun another trial using CRISPR/Cas9 approaches in cancer patients, according to the Wall Street Journal.

In Science this week: human DNA found in sediments from archeological sites lacking bones, and more.